As an example, patients diagnosed with atypical Hemolytic Uremic Syndrome and with a positive genetic report identifying pathogenic variants in CFH, C3 or CFB genes, are at moderate to high risk of recurrence after transplantation [28]. The gene discussed is C3; the disease is hemolytic-uremic syndrome.